CHR has a large number of long-distance patients, including international IVF patients.
[This article deals with a rapidly developing situation. It was written by Norbert Gleicher, MD, on March 12, 2020 and published on March 13, 2020.]
Almost a third of CHR patients travel to our center from out of the U.S. In general, our advice to them does not differ from what has been described in this newsletter. International patients dp need to deal with additional uncertainties of travel and, especially, with federal quarantine rules for certain countries. Currently such rules exist for China, South Korea, Iran, Italy and to a lesser degree, Japan. But things can, and will, change. We, therefore, strongly suggest that you not only check in your country of origin with the U.S. consulate but, also, that you consider coming to NYC a few days earlier than you, otherwise, would have scheduled.
Should you require a VISA to enter the U.S., please let us know and we will gladly provide you with a letter, documenting that the purpose of your entry is medical. In some instances, such a letter may help in speeding up the VISA process.
This is a part of the March 2020 CHR VOICE.
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.
DISCOVER YOUR TREATMENT OPTIONS
